在抑郁症的动物模型中,NitroSynapsin对突触可塑性的恢复作用
Wing Sze Tse1, Bartłomiej Pochwat2, Bernadeta Szewczyk3
1Laboratory of Cell Biophysics, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteur Str. 3, 02-093 Warsaw, Poland.
Neuropharmacology
|October 5, 2023
概括
氨酸 (NS),一种新型的记忆素衍生物,在小鼠抑郁症模型中表现出类似抗抑郁药的效果. 这种化合物逆转了行为缺陷并恢复了突触可塑性,为严重抑郁症治疗提供了有前途的新途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 大型抑郁症 (MDD) 迫切需要新的药理疗法,其发病速度快且有效率高.
- 现有的治疗方法往往有局限性,需要探索新的治疗药物.
- 缺乏心理仿效效应的化合物在MDD治疗中特别受欢迎.
研究的目的:
- 评估NitroSynapsin (NS) 的抗抑郁药物潜力,N-甲基-d-酸盐受体 (NMDAR) 抗剂和记忆素衍生物.
- 评估NS在抑郁症临床前模型中的行为,结构和功能层面的影响.
- 调查NS的机制,包括针对性向NMDARs上抑制性氧化还原位的向输送.
主要方法:
- 利用慢性克制压力 (CRS) 鼠标模型来模拟抑郁症.
- 在连续三天内给压力严重的雄性C57BL/6J小鼠注射了五剂NS.
- 使用糖偏好和尾部悬浮试验评估行为变化.
- 在中部前额叶皮层 (mPFC) 神经元中检查了树突的形态和密度变化.
- 进行了电生理学记录,以评估mPFC中的长期潜能 (LTP).
主要成果:
- 在糖偏好和尾部悬浮试验中,NS的使用逆转了CRS诱导的行为障碍.
- 在mPFC脑皮神经元中,NS治疗恢复了CRS诱导的树突脊柱形态和密度的变化.
- NS阻止了由CRS.引起的mPFC长期增强 (LTP) 的减少.
- NS有效地将结构和功能上的突触可塑性和抑郁行为正常化到天真动物中观察到的水平.
结论:
- 在临床前的抑郁症模型中,NitroSynapsin (NS) 显示出显著的抗抑郁药类强度.
- 纳米素恢复了结构和功能上的突触可塑性,这表明其抗抑郁作用的神经生物学基础.
- 尼斯代表了主要抑郁症治疗的有前途的治疗候选者,需要进一步的临床研究.
相关概念视频
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Long-term Potentiation
2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.8K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


